Correlation Between Meta Platforms and Raphael Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Meta Platforms and Raphael Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Meta Platforms and Raphael Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Meta Platforms and Raphael Pharmaceutical, you can compare the effects of market volatilities on Meta Platforms and Raphael Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Meta Platforms with a short position of Raphael Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Meta Platforms and Raphael Pharmaceutical.

Diversification Opportunities for Meta Platforms and Raphael Pharmaceutical

-0.34

Correlation Coefficient

Meta Platforms  Raphael Pharmaceutical

Very good diversification

The 3 months correlation between Meta and Raphael is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Meta Platforms and Raphael Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Raphael Pharmaceutical and Meta Platforms is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Meta Platforms are associated (or correlated) with Raphael Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Raphael Pharmaceutical has no effect on the direction of Meta Platforms i.e., Meta Platforms and Raphael Pharmaceutical go up and down completely randomly.

Pair Corralation between Meta Platforms and Raphael Pharmaceutical

Given the investment horizon of 90 days Meta Platforms is expected to generate 0.26 times more return on investment than Raphael Pharmaceutical. However, Meta Platforms is 3.91 times less risky than Raphael Pharmaceutical. It trades about 0.15 of its potential returns per unit of risk. Raphael Pharmaceutical is currently generating about 0.01 per unit of risk. If you would invest  11,769  in Meta Platforms on September 13, 2024 and sell it today you would earn a total of  51,499  from holding Meta Platforms or generate 437.58% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.79%
Values	Daily Returns

Meta Platforms  vs.  Raphael Pharmaceutical

Meta Platforms

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Meta Platforms are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat conflicting basic indicators, Meta Platforms sustained solid returns over the last few months and may actually be approaching a breakup point.

Raphael Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Raphael Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Meta Platforms and Raphael Pharmaceutical

The main advantage of trading using opposite Meta Platforms and Raphael Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Meta Platforms position performs unexpectedly, Raphael Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Raphael Pharmaceutical will offset losses from the drop in Raphael Pharmaceutical's long position.

The idea behind Meta Platforms and Raphael Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.